These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


257 related items for PubMed ID: 8122366

  • 21. Expression of class I major histocompatibility complex antigens in Epstein-Barr virus-carrying lymphoblastoid cell lines and Burkitt lymphoma cells.
    Jilg W, Voltz R, Markert-Hahn C, Mairhofer H, Münz I, Wolf H.
    Cancer Res; 1991 Jan 01; 51(1):27-32. PubMed ID: 1899042
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. An origin of DNA replication (oriP) in highly methylated episomal Epstein-Barr virus DNA localizes to a 4.5-kb unmethylated region.
    Falk K, Ernberg I.
    Virology; 1993 Aug 01; 195(2):608-15. PubMed ID: 8393238
    [Abstract] [Full Text] [Related]

  • 24. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    Puglielli MT, Woisetschlaeger M, Speck SH.
    J Virol; 1996 Sep 01; 70(9):5758-68. PubMed ID: 8709191
    [Abstract] [Full Text] [Related]

  • 25. Contrasting effects of hydroxyurea on cell growth and reduction in Epstein-Barr virus genomes in EBV-infected epithelioid cell lines vs Burkitt's lymphoma cell lines.
    Jiang R, Kanamori M, Satoh Y, Fukuda M, Ikuta K, Murakami M, Sairenji T.
    J Med Virol; 2003 Jun 01; 70(2):244-52. PubMed ID: 12696111
    [Abstract] [Full Text] [Related]

  • 26. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
    Cuomo L, Trivedi P, de Grazia U, Calogero A, D'Onofrio M, Yang W, Frati L, Faggioni A, Rymo L, Ragona G.
    J Med Virol; 1998 Jul 01; 55(3):219-26. PubMed ID: 9624610
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Characterization of Epstein-Barr virus recombinants with deletions of the BamHI C promoter.
    Swaminathan S.
    Virology; 1996 Mar 15; 217(2):532-41. PubMed ID: 8610445
    [Abstract] [Full Text] [Related]

  • 29. Selective loss of integrated Epstein-Barr virus genomes after long-term cultivation of Burkitt's lymphoma x B-lymphoblastoid cell hybrids due to chromatin instability at the integration site.
    Wolf J, Jox A, Skarbek H, Pukrop T, Bartnitzke S, Pawlita M, Diehl V, Bullerdiek J.
    Virology; 1995 Sep 10; 212(1):179-85. PubMed ID: 7676627
    [Abstract] [Full Text] [Related]

  • 30. Examination of Epstein-Barr virus and C-type proviral sequences in American and African lymphomas and derivative cell lines.
    Pizzo PA, Chattopadhyay SK, Magrath IT, Del Giacco E, Sherrick D, Gray T.
    Cancer Res; 1981 Aug 10; 41(8):3165-71. PubMed ID: 6265077
    [Abstract] [Full Text] [Related]

  • 31. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG, Zhang QJ, Gavioli R, De Campos-Lima PO, Murray RJ, Brooks J, Griffin H, Ploegh H, Rickinson AB.
    Int Immunol; 1992 Nov 10; 4(11):1283-92. PubMed ID: 1282031
    [Abstract] [Full Text] [Related]

  • 32. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.
    Hutchings IA, Tierney RJ, Kelly GL, Stylianou J, Rickinson AB, Bell AI.
    J Virol; 2006 Nov 10; 80(21):10700-11. PubMed ID: 16920819
    [Abstract] [Full Text] [Related]

  • 33. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.
    Kryworuckho M, Diaz-Mitoma F, Kumar A.
    Immunology; 1995 Sep 10; 86(1):41-8. PubMed ID: 7590880
    [Abstract] [Full Text] [Related]

  • 34. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines.
    Schaefer BC, Strominger JL, Speck SH.
    J Virol; 1995 Aug 10; 69(8):5039-47. PubMed ID: 7609074
    [Abstract] [Full Text] [Related]

  • 35. Cell phenotype dependent expression of MHC class I antigens in Burkitt's lymphoma cell lines.
    Masucci MG, Klein E.
    Semin Cancer Biol; 1991 Feb 10; 2(1):63-71. PubMed ID: 1655115
    [Abstract] [Full Text] [Related]

  • 36. IL6 and IL6 receptor expression in Burkitt's lymphoma and lymphoblastoid cell lines: promotion of IL6 receptor expression by EBV.
    Klein SC, Jücker M, Abts H, Tesch H.
    Hematol Oncol; 1995 Feb 10; 13(3):121-30. PubMed ID: 7622142
    [Abstract] [Full Text] [Related]

  • 37. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.
    Young LS, Yao QY, Rooney CM, Sculley TB, Moss DJ, Rupani H, Laux G, Bornkamm GW, Rickinson AB.
    J Gen Virol; 1987 Nov 10; 68 ( Pt 11)():2853-62. PubMed ID: 2824665
    [Abstract] [Full Text] [Related]

  • 38. Phenotype-dependent differences in proteasome subunit composition and cleavage specificity in B cell lines.
    Frisan T, Levitsky V, Polack A, Masucci MG.
    J Immunol; 1998 Apr 01; 160(7):3281-9. PubMed ID: 9531285
    [Abstract] [Full Text] [Related]

  • 39. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines.
    Nakagomi H, Dolcetti R, Bejarano MT, Pisa P, Kiessling R, Masucci MG.
    Int J Cancer; 1994 Apr 15; 57(2):240-4. PubMed ID: 8157362
    [Abstract] [Full Text] [Related]

  • 40. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
    Finke J, Rowe M, Kallin B, Ernberg I, Rosén A, Dillner J, Klein G.
    J Virol; 1987 Dec 15; 61(12):3870-8. PubMed ID: 2824821
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.